Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma. - Wikidata - awgldk - TriplyDB

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

http://www.wikidata.org/entity/Q33704207

about

Targeted Radionuclide Therapy of Human Tumors In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression.Improved detection of lung or bone metastases with an I-131 whole body scan on the 7th day after high-dose I-131 therapy in patients with thyroid cancer The Effect of Tanespimycin (17-AAG) on Radioiodine Accumulation in Sodium-Iodide Symporter Expressing Cells.The effectiveness of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal prior to radioiodine remnant ablation in thyroid cancer: a meta-analysis of randomized controlled trials Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology.Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes.Relations Between Pathological Markers and Radioiodine Scan and (18)F-FDG PET/CT Findings in Papillary Thyroid Cancer Patients With Recurrent Cervical Nodal Metastases.Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer.Quantitative single-photon emission computed tomography/computed tomography for technetium pertechnetate thyroid uptake measurement.Comparison of 18F-fluorodeoxyglucose uptake with the expressions of glucose transporter type 1 and Na+/I- symporter in patients with untreated papillary thyroid carcinoma.Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer.Urinary Iodine Concentrations in Cancer Patients Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy.Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature.The comparison of (131)I whole-body scans on the third and tenth day after (131)I therapy in patients with well-differentiated thyroid cancer: preliminary report.Utility of Quantitative Parameters from Single-Photon Emission Computed Tomography/Computed Tomography in Patients with Destructive Thyroiditis.Recent Development of Nuclear Molecular Imaging in Thyroid Cancer.

P2860

Q26771267-43351136-67FA-4AC4-B49D-24865CA835D9 Q33670033-1309DB90-67DB-4FD0-8766-D1452DCD9EC5 Q33704024-0D959C4F-EE0F-436C-8921-3931048A7397 Q33704634-1A34369D-B102-4B1C-B7C4-1C3ACEABE71E Q33749205-5BA08CC6-AF0D-4746-9F3D-5F13C0608C4F Q34318846-84C9D345-301C-4F5D-BFD4-929C758BE803 Q34698684-6D05FA43-204C-43AF-86F9-B713FABED91D Q35605392-0B202820-77C9-4C8B-B6B8-DB3740EF84A7 Q35724898-EF1E2A2A-B470-4F81-A905-EA3A63BB6BE3 Q37077255-A3DEA999-D9EF-452D-8C1D-F93208EB6054 Q37328188-818D6648-33D3-4479-BD61-BA8F2C5DD6AA Q38459560-6816AA58-A7FB-4F07-919F-221B0AD1708F Q38472945-082D69DD-CD98-4420-BD0A-18BD60EB607E Q41860336-E69AC545-59D6-445D-A0B5-11A1D70B4497 Q46073511-59FE2B57-7CFE-448E-943D-75DE2834DCB0 Q47585238-FB47E693-D6AE-4A07-8264-606C617384B3 Q51479311-DDC8F67D-0041-482C-B65E-F8CF3DC97C91 Q55026370-111A8865-5963-4971-AB56-F83018734BC0 Q55413120-F474D71D-A90D-401B-9F90-F4C3CD99BB09

P2860

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

http://www.wikidata.org/entity/Q33704207

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

@ast

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

@en

type

label

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

@ast

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

@en

prefLabel

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

@ast

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

@en

P1433

Q33704207-9AA39C41-8688-4CE7-93BC-83A9C5AE9B04

P1476

Q33704207-3E4F86C0-DADD-45EF-9BEB-3110C38F52D9

P2093

Q33704207-4A854495-3FF8-4FFC-9428-49B969FDB7F4

Q33704207-A637FB29-51D7-4C20-8876-6376DBA76740

Q33704207-B5B50941-5789-4E5F-BF0C-455E9C599491

Q33704207-C3D319FA-8E53-410A-98CF-09C5A7AC6968

P2860

Q33704207-046C5CD4-5B71-4A43-8413-04FE9F66AA38

Q33704207-0A237C22-920A-42C9-A05F-0C74102DFF11

Q33704207-0E21201B-6CBA-4FFB-A5C2-75BF049B3822

Q33704207-138FD9F9-1787-4E89-B531-DAB491B845EF

Q33704207-1A6F2812-03E0-4BA5-A2E2-71B01D33E294

Q33704207-1C262EE1-E9CB-4CA5-8C60-4C58D0C016F6

Q33704207-1C70B080-F620-4BDC-80CE-F607F4C0E16F

Q33704207-202E4A18-BE98-4370-8F8D-D004D70226C4

Q33704207-2167179F-06D2-4139-8DF0-3D1FAA3CCC1F

Q33704207-2AAA8116-8FC6-4436-B0E4-AE9563EF3C4F

P2888

Q33704207-2A657B13-38C6-4BEA-9DDC-3ED874DC1104

P304

Q33704207-3B5B933D-7127-439A-9666-7EAB28A05BB6

P31

Q33704207-1D3F458E-8511-49EC-95E3-0A7BE4FA8E32

P356

Q33704207-0AD47F6B-26FB-48DD-83A6-B7DA218D8F23

P433

Q33704207-E1887BF8-B4F3-4C2B-8867-A571445E0234

P478

Q33704207-BB9AD134-6F34-43D0-9850-343BEB13AC3C

P50

Q33704207-90B21CA6-C9CA-4FF7-9764-377BCECB2250

P577

Q33704207-6BA6FCFF-7BED-44E2-BBFC-78EDBE6BB91A

P6179

Q33704207-9FFCAEC3-CBEA-4586-9E02-56DEDB795BA1

P698

Q33704207-2E4024F5-8571-4E43-9B51-DCCC1B7947CD

P932

Q33704207-366E5C70-27E5-46D3-A8A0-0E4EBAFDF344

P356

S13139-009-0016-1

P1433

Nuclear medicine and molecular imaging NMMI

P1476

Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

@en

P2093

Ho Young Lee

http://www.w3.org/2001/XMLSchema#string

Joo Hyun Kang

http://www.w3.org/2001/XMLSchema#string

June-Key Chung

http://www.w3.org/2001/XMLSchema#string

Keon Wook Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta/FoxA2, TTF-1 and C/EBP beta in thyroid carcinoma cells

The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance

Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines

Enhancement of sodium/iodide symporter expression in thyroid and breast cancer

Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50

Cloning and characterization of the thyroid iodide transporter

Thyroid Development and Its Disorders: Genetics and Molecular Mechanisms

Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.

Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.

The Na/I symporter (NIS): imaging and therapeutic applications.

P2888

s13139-009-0016-1

P304

4-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13139-009-0016-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1025415769

http://www.w3.org/2001/XMLSchema#string

P698

24899932

http://www.w3.org/2001/XMLSchema#string

P932

4042960

http://www.w3.org/2001/XMLSchema#string